Novartis India

71
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,970.55
-56.3 (-2.78%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 33.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
354.00
707.00
-353.00
-49.93%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
354.00
707.00
-353.00
-49.93%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
-21.00
9.00
42.86%
Raw Materials Consumed
210.00
274.00
-64.00
-23.36%
Power & Fuel Cost
0.00
18.00
-18.00
-100.00%
Employee Cost
21.00
141.00
-120.00
-85.11%
Operating Expenses
9.00
30.00
-21.00
-70.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
11.00
31.00
-20.00
-64.52%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
19.00
-13.00
-68.42%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
260.00
559.00
-299.00
-53.49%
Operating Profit (PBDIT) excl Other Income
94.00
148.00
-54.00
-36.49%
Other Income
38.00
25.00
13.00
52.00%
Operating Profit (PBDIT)
132.00
173.00
-41.00
-23.70%
Interest
1.00
1.00
0.00
0.00%
Profit before Depriciation and Tax
131.00
171.00
-40.00
-23.39%
Depreciation
1.00
21.00
-20.00
-95.24%
Profit Before Taxation & Exceptional Items
129.00
150.00
-21.00
-14.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
154.00
-25.00
-16.23%
Provision for Tax
36.00
39.00
-3.00
-7.69%
Profit After Tax
93.00
115.00
-22.00
-19.13%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
768.00
474.00
294.00
62.03%
Profit Available for appropriations
862.00
589.00
273.00
46.35%
Appropriations
862.00
589.00
273.00
46.35%
Equity Dividend (%)
500%
300%
200.00
Earnings Per Share
37.74
69.64
-31.90
-45.81%
Profit And Loss - Net Sales
Net Sales 354.33 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

Profit And Loss - Interest
Interest 1.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 93.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025

Footer loading